Speech-Language Pathologists in Kilmarnock, VA Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Susan A. Rose, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45 North Main Street, Kilmarnock, VA 22482 Phone: 804-435-0758 Fax: 804-435-7226 |
Janet Lee Gilbert Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 41 Noblett Lane, Kilmarnock, VA 22482 Phone: 757-718-2811 |
Julie Saccogna, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 43 William B Graham Ct, Kilmarnock, VA 22482 Phone: 804-435-8501 |
Kirby Evett, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 43 William B Graham Ct, Kilmarnock, VA 22482 Phone: 804-435-8501 |
News Archive
Phase III study results on miconazole Lauriad presented by BioAlliance Pharma
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, has presented results on miconazole Lauriad® at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia (October 29 – November 1st).
Presence of plaque on abdominal CT scan: Strong predictor of coronary artery disease and mortality
The presence of plaque on an abdominal CT scan is a strong predictor of coronary artery disease and mortality, according to a Henry Ford Hospital study.
Evaluating all Medicare plan options can reduce healthcare costs
Nearly 8 million former workers have disabilities so severe that they rely on Social Security Disability Insurance benefits, and an estimated 3.3 million more will apply for disability benefits this year. For these people and others suffering from serious conditions and disabilities, taking the right steps quickly to manage costs is essential for their financial and health well-being, according to Allsup, a nationwide provider of Social Security disability representation and Medicare plan selection services.
Roche, Merck sign new non-exclusive agreement for HCV triple combination therapy
Merck, known as MSD outside the United States and Canada, announced today that it has signed a new non-exclusive agreement with Roche, through the companies' respective subsidiaries, for the global promotion, upon appropriate marketing approvals, of VICTRELIS (boceprevir) as part of a triple combination therapy regimen with peginterferon alfa and ribavirin.
› Verified 2 days ago
Physical Therapists
Chiropractors
Audiologists
Speech-Language Pathologists
Occupational Therapists